DOI: 10.1055/s-00000069

Seminars in Liver Disease

References

Kazankov K, Barrera F, Møller HJ. , et al.
The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease.

Liver Int 2016;
36 (10) 1549-1557

Download Bibliographical Data

Access:
Access: